This is further supported by evidence highlighting HMGB1’s dual role in the early inflammatory response and neurovascular remodeling during stroke recovery, underscoring the potential of targeting HMGB1 as a therapeutic strategy to reduce stroke-induced damage [67,68]. This evidence concerns the gene HMGB1 and Stroke.